Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.
Market Cap:5.4M; Shares Outstanding:3.9M; Short Interest: 1.18%; Q3 2019(9/30/19): Cash 7.3M. Loss 6.31M
EPS and Sales:
|Date||EPS||% last year||% last quarter|
|Date||Sales||% last year||% last quarter|
Total institutions: 31，no change
Shares hold: 474.7k shares. no change
shares% hold: 12.28%，no change